Exercise Improve Sympathetic Modulation in Chronic Heart Failure Patients
NCT02219451 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 26
Last updated 2014-08-19
Summary
The purpose of this study is to verify the effects of exercise training on sympathetic modulation and arterial baroreflex control in patients with chronic heart failure.
Conditions
Interventions
- OTHER
-
exercise training
exercise training
Sponsors & Collaborators
-
InCor Heart Institute
collaborator OTHER -
University of Sao Paulo General Hospital
lead OTHER
Principal Investigators
-
Heart Institute HC/FMUSP, HC/FMUSP · Heart Institute, University of Sao Paulo
Study Design
- Allocation
- NA
- Masking
- SINGLE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 30 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-08-31
- Primary Completion
- 2014-04-30
- Completion
- 2014-07-31
Countries
- Brazil
Study Locations
More Related Trials
-
The Effect of Beta-blocker on Chronotropic Response and Cardiorespiratory Fitness in Patients With Atrial Fibrillation
NCT05332457 ·Status: RECRUITING ·Phase: NA
-
The Influence of Beta Blocker Therapy on the Hemodynamic Response to Inotrope Infusion in Patients With Acute Decompensated Heart Failure
NCT01971944 ·Status: COMPLETED
-
The Link Between the Clinical Resting Heart Rate and Sympathetic Overactivation
NCT02315313 ·Status: UNKNOWN
-
Mental Stress, Autonomic Function, and Heart Disease
NCT00005524 ·Status: COMPLETED
-
Clinical Assessment of the Treatment With Cardiac Sympathetic Blockade on Chronic Heart Failure
NCT02391142 ·Status: UNKNOWN ·Phase: NA
-
Clinical Autonomic Disorders: A Training Protocol
NCT02154009 ·Status: TERMINATED
-
The Prognostic Role of Indices of Sympathetic Nervous System Overdrive in MINOCA
NCT04681612 ·Status: UNKNOWN
-
Sympathetic and Vascular Function in Takotsubo Syndrome
NCT05768542 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Effect of Beta-blockers on Structural Remodeling and Gene Expression in the Failing Human Heart
NCT01798992 ·Status: COMPLETED ·Phase: PHASE4
-
Cardiac Autonomic Nerve Improvement and Pacemaker Therapy in Patients With Sinus Bradycardia
NCT05021627 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Effect Baroreflex Activation Therapy on the Carotid Body
NCT02210923 ·Status: UNKNOWN
-
Cardiovascular and Cerebrovascular Control in Healthy Subjects
NCT05706532 ·Status: RECRUITING
-
The Effects Of Bronchodilator Therapy On Respiratory And Autonomic Function In Patients With Familial Dysautonomia
NCT01987219 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of Nebivolol and Metoprolol With Exercise and Angiotensin II in Hypertensive Patients
NCT01502787 ·Status: COMPLETED ·Phase: PHASE4
-
Pulse Reduction On Beta-blocker and Ivabradine Therapy
NCT02973594 ·Status: COMPLETED ·Phase: PHASE4
-
High Resolution Phenotyping in Healthy Humans
NCT00943774 ·Status: COMPLETED
-
Pathophysiology of Orthostatic Intolerance
NCT00608725 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Cardiovascular Effects of Selective I(f)-Channel Blockade
NCT00865917 ·Status: UNKNOWN ·Phase: PHASE2
-
Effect of Beta Blockade on Left Ventricular Remodeling and Function in Moderate to Severe Asymptomatic Aortic Regurgitation
NCT01157572 ·Status: COMPLETED ·Phase: PHASE4
-
Targeting Sympathetic Overactivity in Heart Failure Patients With Statins
NCT01097785 ·Status: COMPLETED ·Phase: NA
-
Beta2-adrenergic System and Training
NCT04616261 ·Status: UNKNOWN ·Phase: NA
-
POTS Adrenergic Ab (CIHR Aims #1&2)
NCT02673996 ·Status: RECRUITING
-
Effect of Nicorandil on Cardiac Sympathetic Nerve for the Patients of Acute ST Segment Elevation Myocardial Infarction
NCT04826497 ·Status: UNKNOWN ·Phase: PHASE4
-
Beta-blockers in i-PAH
NCT01246037 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Vascular Sensitivity to Adrenergic Agonists in Patients With CHF and in Healthy Subjects
NCT00782782 ·Status: UNKNOWN